| Veröffentlichte Version Download ( PDF | 266kB) | Lizenz: Creative Commons Namensnennung 4.0 International |
Determination of free clindamycin, flucloxacillin or tedizolid in plasma: Keep attention to physiological conditions when using ultrafiltration
Dorn, Christoph
, Schießer, Selina, Wulkersdorfer, Beatrix, Hitzenbichler, Florian, Kees, Martin G.
und Zeitlinger, Markus
(2020)
Determination of free clindamycin, flucloxacillin or tedizolid in plasma: Keep attention to physiological conditions when using ultrafiltration.
Biomedical Chromatography 34, e4820.
Veröffentlichungsdatum dieses Volltextes: 19 Mrz 2020 10:24
Artikel
DOI zum Zitieren dieses Dokuments: 10.5283/epub.43002
Zusammenfassung
Pharmacokinetic/pharmacodynamic indices of anti-infective drugs should be referenced to free drug concentrations. In the present study, clindamycin, flucloxacillin and tedizolid have been determined in human plasma by HPLC-UV. The drugs were separated isocratically within 3-6 min on a C-18 column using mixtures of phosphate buffer-acetonitrile of pH 7.1-7.2. Sample treatment for the determination ...
Pharmacokinetic/pharmacodynamic indices of anti-infective drugs should be referenced to free drug concentrations. In the present study, clindamycin, flucloxacillin and tedizolid have been determined in human plasma by HPLC-UV. The drugs were separated isocratically within 3-6 min on a C-18 column using mixtures of phosphate buffer-acetonitrile of pH 7.1-7.2. Sample treatment for the determination of total drug concentrations in plasma included extraction/back-extraction (clindamycin) or protein precipitation (flucloxacillin, tedizolid). The free drug concentrations were determined after ultrafiltration. An ultrafiltration device with a membrane consisting of regenerated cellulose proved to be suitable for all drugs. Maintaining a physiological pH was crucial for clindamycin, whereas maintaining body temperature was essential for tedizolid. The methods were applied to the analysis of total and free drug concentrations in clinical samples and were sufficiently sensitive for pharmacokinetic studies and therapeutic drug monitoring.
Alternative Links zum Volltext
Beteiligte Einrichtungen
Details
| Dokumentenart | Artikel | ||||
| Titel eines Journals oder einer Zeitschrift | Biomedical Chromatography | ||||
| Verlag: | Wiley | ||||
|---|---|---|---|---|---|
| Ort der Veröffentlichung: | HOBOKEN | ||||
| Band: | 34 | ||||
| Seitenbereich: | e4820 | ||||
| Datum | 1 März 2020 | ||||
| Institutionen | Medizin > Lehrstuhl für Anästhesiologie Medizin > Lehrstuhl für Innere Medizin I Chemie und Pharmazie > Institut für Pharmazie Chemie und Pharmazie > Institut für Pharmazie > Arbeitsgruppe Klinische Pharmazie (Dr. Dorn) | ||||
| Identifikationsnummer |
| ||||
| Stichwörter / Keywords | PROTEIN-BINDING; IMPACT; HPLC-UV; lincosamide; oxazolidinone; penicillin; protein binding; therapeutic drug monitoring | ||||
| Dewey-Dezimal-Klassifikation | 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin 600 Technik, Medizin, angewandte Wissenschaften > 615 Pharmazie | ||||
| Status | Veröffentlicht | ||||
| Begutachtet | Ja, diese Version wurde begutachtet | ||||
| An der Universität Regensburg entstanden | Ja | ||||
| URN der UB Regensburg | urn:nbn:de:bvb:355-epub-430020 | ||||
| Dokumenten-ID | 43002 |
Downloadstatistik
Downloadstatistik